These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6753613)

  • 1. The double-blind in danger: untoward consequences of informed consent.
    Brownell KD; Stunkard AJ
    Am J Psychiatry; 1982 Nov; 139(11):1487-9. PubMed ID: 6753613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How blind is double-blind? A study of fish oil versus placebo.
    Damico KE; Stoll AL; Marangell LB; Cohen BM
    Prostaglandins Leukot Essent Fatty Acids; 2002 Apr; 66(4):393-5. PubMed ID: 12054908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack Trial.
    Byington RP; Curb JD; Mattson ME
    JAMA; 1985 Mar 22-29; 253(12):1733-6. PubMed ID: 3974051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More on the fallibility of the double-blind.
    Barsa JA
    Am J Psychiatry; 1983 Jun; 140(6):820-1. PubMed ID: 6846655
    [No Abstract]   [Full Text] [Related]  

  • 5. [How blind is a double-blind trial really? Validity of controlled investigations].
    Modestin J; Hodel J
    Int Pharmacopsychiatry; 1977; 12(3):129-36. PubMed ID: 334685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untoward effects of fenfluramine in autistic children.
    Realmuto GM; Jensen J; Klykylo W; Piggott L; Stubbs G; Yuwiler A; Geller E; Freeman BJ; Ritvo E
    J Clin Psychopharmacol; 1986 Dec; 6(6):350-5. PubMed ID: 3543069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug side effects and the double-blind design.
    Robinson ML
    Am J Psychiatry; 1988 Apr; 145(4):539. PubMed ID: 3348469
    [No Abstract]   [Full Text] [Related]  

  • 8. [Informed consent, what information is left after a therapeutic trial?].
    Gallet M; Aupetit JF; Servan E; Lestaevel M; Lopez M; Chassoux G
    Arch Mal Coeur Vaiss; 1994 Jan; 87(1):39-45. PubMed ID: 7811150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder.
    Chouinard G
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):32-7. PubMed ID: 3882679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blinding in clinical trials.
    Ney PG
    CMAJ; 1989 Jan; 140(1):15. PubMed ID: 2909265
    [No Abstract]   [Full Text] [Related]  

  • 11. Making moral decisions on a double-blinded drug trial in progress without breaking the code: a primer on posterior analysis.
    Allen AD
    Med Decis Making; 1989; 9(3):207-16. PubMed ID: 2668682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Informed consent in a clinical trial of a novel treatment for rheumatoid arthritis.
    Criscione LG; Sugarman J; Sanders L; Pisetsky DS; St Clair EW
    Arthritis Rheum; 2003 Jun; 49(3):361-7. PubMed ID: 12794792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The therapeutic effect of Fenfluramine on body weight in overweight patients. A controlled clinical study].
    Haug E; Myklebust R
    Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2545-9. PubMed ID: 4589598
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind, placebo-controlled assessment of nortriptyline's side-effects during 3-year maintenance treatment in elderly patients with recurrent major depression.
    Marraccini RL; Reynolds CF; Houck PR; Miller MD; Frank E; Perel JM; Cornes C; Mazumdar S; Kupfer DJ
    Int J Geriatr Psychiatry; 1999 Dec; 14(12):1014-8. PubMed ID: 10607968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions to triazolam, flurazepam, and placebo in controlled clinical trials.
    Greenblatt DJ; Shader RI; Divoll M; Harmatz JS
    J Clin Psychiatry; 1984 May; 45(5):192-5. PubMed ID: 6144670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodologic approach to adverse events applied to bupropion clinical trials.
    Cato AE; Cook L; Starbuck R; Heatherington D
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):187-90. PubMed ID: 6406455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind assessment of therapeutic efficacy in clinical trials.
    Cohen S
    Dig Dis Sci; 1983 Jun; 28(6):564-5. PubMed ID: 6861586
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study.
    Silberstein S; Saper J; Berenson F; Somogyi M; McCague K; D'Souza J
    Neurology; 2008 Feb; 70(7):548-55. PubMed ID: 18268247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Informed consent when prescribing medication: a randomized controlled trial.
    Glicksman JT; Sherman I; Rotenberg BW
    Laryngoscope; 2014 Jun; 124(6):1296-300. PubMed ID: 24222009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised clinical trial of the effect of informed consent on the analgesic activity of placebo and naproxen in cancer pain.
    Bergmann JF; Chassany O; Gandiol J; Deblois P; Kanis JA; Segrestaa JM; Caulin C; Dahan R
    Clin Trials Metaanal; 1994 Apr; 29(1):41-7. PubMed ID: 10150184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.